Germany working to ensure continued cooperation between BioNTech, Chinese partner

Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed Biontech logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic

BERLIN, Nov 28 (Reuters) - Germany is working to ensure cooperation between BioNTech and its Chinese partner on the COVID-19 vaccine moves forward, a German government spokesperson said on Monday.

German Chancellor Olaf Scholz announced an agreement earlier this month to let expatriates in China use the COVID-19 vaccine from Germany's BioNTech (22UAy.DE) on his first visit to China since becoming chancellor.

The spokesperson added that the German government had taken note of protests in several large Chinese cities against a strict zero-COVID policy, including violent treatment.

Reporting by Andreas Rinke and Rachel More, Writing by Miranda Murray, Editing by Paul Carrel

Our Standards: The Thomson Reuters Trust Principles.

Read Next